|
|
|
|
Vol. 59, Issue 5, 1129-1137, May 2001
Institute of Pharmacology (H.H.S., P.S., B.H., E.A.S.) and Brain Research Institute (C.P.), University of Vienna, Vienna, Austria
| |
Abstract |
|---|
|
|
|---|
Quantitative aspects of inward and outward transport of substrates by the human plasmalemmal serotonin transporter (hSERT) were investigated. Uptake and superfusion experiments were performed on human embryonic kidney 293 cells permanently expressing the hSERT using [3H]serotonin (5-HT) and [3H]1-methyl-4-phenylpyridinium (MPP+) as substrates. Saturation analyses rendered Km values of 0.60 and 17.0 µM for the uptake of [3H]5-HT and [3H]MPP+, respectively. Kinetic analysis of outward transport was performed by prelabeling the cells with increasing concentrations of the two substrates and exposing them to a saturating concentration of p-chloroamphetamine (PCA; 10 µM). Apparent Km values for PCA induced transport were 564 µM and about 7 mM intracellular [3H]5-HT and [3H]MPP+, respectively. Lowering the extracellular Na+ concentrations in uptake and superfusion experiments revealed differential effects on substrate transport: at 10 mM Na+ the Km value for [3H]5-HT uptake increased ~5-fold and the Vmax value remained unchanged. The Km value for [3H]MPP+ uptake also increased, but the Vmax value was reduced by 50%. When efflux was studied at saturating prelabeling conditions of both substrates, PCA as well as unlabeled 5-HT and MPP+ (all substances at saturating concentrations) induced the same efflux at 10 mM and 120 mM Na+. Thus, notwithstanding a 50% reduction in the Vmax value of transport into the cell, MPP+ was still able to induce maximal outward transport of either substrate. Thus, hSERT-mediated inward and outward transport seems to be independently modulated and may indicate inconsistencies with the classical model of facilitated exchange diffusion.
| |
Introduction |
|---|
|
|
|---|
Synaptic
clearance of serotonin [5-hydroxytryptamine (5-HT)] after release
from nerve terminals is determined by the action of the plasma membrane
serotonin transporter (SERT). SERT-mediated 5-HT uptake is driven by
transmembrane ion gradients (Rudnick, 1997
) and is blocked by a variety
of drugs most prominently the tricyclic antidepressants (e.g.,
imipramine) and the selective serotonin uptake inhibitors (e.g.,
fluoxetine). As postulated by the theory of facilitated exchange
diffusion drugs causing 5-HT release are substrates of the transporter
(e.g., the amphetamine derivatives such as
para-chloroamphetamine, PCA), are taken up into the cells,
and lead to an increase in the availability of inward-facing
transporter binding sites for efflux of cytoplasmic 5-HT (Fuller et
al., 1965
; Fischer and Cho, 1979
; Trendelenburg, 1989
; Rudnick and
Wall, 1992a
,b
; Gobbi et al., 1993
; Rudnick, 1997
). In this
strict alternating access model, the rate of extracellular solute
influx determines the rate of intracellular solute efflux. The faster
the carrier can flip to the inside, the faster it can return to the
outside carrying the effluxed substrate. In such a model one
would expect influx and efflux rates to be modulated equivalently.
Although there is a wealth of data on the kinetic features of 5-HT
inward transport in various experimental systems such as brain slices
(Ross and Renyi, 1975
), synaptosomes (Gobbi et al., 1993
), platelets
(Rudnick, 1977
), and cells transfected with the SERT cDNA (Barker et
al., 1994
), information on outward transport is much more limited in
this respect. Although cloning and heterologous expression of the human
SERT (hSERT) in mammalian cells has made it possible to study the
transporter function isolated from interfering factors such as
vesicular storage or exocytotic release (Ramamoorthy et al., 1993
), the
acquirement of quantitative data on outward transport has remained difficult.
Important contributions on human dopamine and norepinephrine
transporters (human DAT and hNET, respectively) have been provided by
Justice's group using rotating disk electrode voltammetry (RDEV; Burnette et al., 1996
; Chen et al., 1998
, 1999
; Chen and Justice, 1998
). There are, nevertheless, no data on 5-HT transport obtained by
this method. Moreover, RDEV, although providing excellent time resolution of transport in the second time frame, does not allow the
change of media during the course of an experiment. Thus, the
investigation of reverse transport caused by a change in the ionic
composition of the medium is not possible. In the present experiments,
we have used a superfusion system to study outward transport of
[3H]5-HT from human embryonic kidney 293 cells
(HEK 293 cells) expressing the hSERT. Two different labeled substrates
were used to preload the cells: [3H]5-HT, the
physiological substrate, which is able to diffuse through lipid
bilayers easily relative to
[3H]1-methyl-4-phenylpyridinium
([3H]MPP+), which is less
lipophilic and therefore passes biological membranes to a smaller
extent (Scholze et al., 2000
). Release of radiolabel was initiated by
adding transporter substrates to the medium (PCA, unlabeled 5-HT, or
MPP+) or by lowering the extracellular
Na+ concentration, a measure known to favor
reverse function of monoamine transporters (Liang and Rutledge, 1982
;
Bönisch, 1986
; Chen et al., 1998
; Pifl and Singer, 1999
). The
experiments allowed us to describe kinetic properties of hSERT-mediated
outward transport in quantitative terms and to relate them to data on
inward transport obtained in the same cells. The fact that different
substrates were used for labeling the cells and that outward transport
was triggered by different means revealed additional information
regarding the molecular mechanisms of the translocation process of
hSERT substrates. The present analyses demonstrate that at lowered
extracellular Na+ concentrations inward transport
of MPP+, but not of 5-HT, is substantially
reduced, whereas outward transport remains fully operative in cells
preloaded with either substrate.
| |
Materials and Methods |
|---|
|
|
|---|
Cell Line Transfection
The cDNA for the human plasmalemmal serotonin transporter
(Ramamoorthy et al., 1993
) was a generous gift of Dr. R. D. Blakely (Department of Pharmacology and Center for Molecular
Neuroscience, School of Medicine, Vanderbilt University, Nashville,
TN). The coding region was subcloned into pEGFP-C1 (CLONTECH, Palo
Alto, CA) removing the GFP coding region as described previously
(Scholze et al., 2000
; thus producing an hSERT lacking any GFP tag).
For stable expression into HEK 293 cells the same method was used as
described previously (Pifl et al., 1996
). The stable transfectants (hSERT cells) were grown in minimal essential medium with Earle's salts and L-analyl-L-glutamine
(L-glutamax I; Life Technologies, Grand Island, NY),
10% heat-inactivated fetal bovine serum, 50 mg/l gentamicin, and 500 µg/ml geneticin (G418) on 100-mm-diameter cell culture dishes at
37°C in an atmosphere of 5% CO2, 95% air.
Uptake Experiments
The experiments were performed as described previously (Scholze
et al., 2000
). In brief, 5 × 104 cells were
seeded onto poly(D-lysine)-coated 24-well plates, and
influx was measured 2 days after plating. Each well was washed twice
with 1 ml of Krebs-Ringer-HEPES buffer (10 mM HEPES, 120 mM NaCl, 3 mM
KCl, 2 mM CaCl2, 2 mM
MgCl2, 20 mM glucose, final pH 7.3). The cells
were incubated with 0.2 µCi of [3H]5-HT (24.5 Ci/mmol) or [3H]MPP+
(77.5 Ci/mmol), and various concentrations of unlabeled 5-HT or
MPP+ in a final volume of 0.2 ml. After the given
incubation period at room temperature, the uptake buffer was aspirated
rapidly and the cells were washed twice with 1 ml of ice-cold buffer.
Cells were lysed with 0.5 ml of 1% SDS and transferred into
scintillation vials for liquid scintillation counting. Nonspecific
uptake was defined as uptake in the presence of 30 µM clomipramine
and amounted to less than 2% of the total uptake. In some experiments
low sodium buffers (0, 3, 10, 30, or 60 mM Na+)
were used (NaCl was iso-osmotically replaced by choline chloride). The
Vmax values for both substrates used in
this study declined over time, indicating a reduction in the expression
level during subsequent passages. The reason for this is not known; one
possible explanation is a time-dependent increase of the amount of
transporter being phosphorylated followed by internalization for
recycling (Ramamoorthy and Blakely, 1999
).
Superfusion Experiments
Cells were grown overnight on round glass coverslips (5-mm
diameter; 4 × 104 cells/coverslip)
incubated with [3H]5-HT or
[3H]MPP+ at different
concentrations for 20 min at 37°C in a final volume of 0.225 ml of
culture medium. Coverslips were then transferred to small superfusion
chambers (0.2 ml) and superfused with Krebs-Ringer-HEPES buffer
(25°C, 0.7 ml/min) as described previously (Pifl et al., 1995
). After
a washout period of 45 min to establish a stable efflux of
radioactivity the experiment was started with the collection of
fractions (4-min or 30-s duration). At the end of the experiment cells
were lysed in 1% SDS. Tritium in the superfusate fractions and in the
SDS-lysates was determined by liquid scintillation counting.
High-performance liquid chromatography analysis revealed that >95% of
the radioactivity in superfusates and cells coeluted with authentic
[3H]5-HT (Scholze et al., 2000
). Release of
3H was expressed either quantitatively
(pmol/min/106 cells or pmol/min) or as fractional
rate; i.e., the radioactivity released during a fraction was expressed
as percentage of the total radioactivity present in the cells at the
beginning of that fraction.
Determination of Cell Numbers per Coverslip. For the estimation of the number of cells used in the superfusion experiments, 4 × 104 cells were seeded onto round glass coverslips and grown overnight. Then the coverslips were removed from the cell culture wells, washed, immersed in 60 µl of 1% SDS, and the protein content of the cell lysate was measured (bicinchoninic acid kit; Pierce, Rockford, IL). Cell numbers were calculated using a standard curve generated on the same day from known amounts of the same cells. This assay was performed in six parallel incubations on five different days and yielded a mean cell number of 27,165 ± 2,822/coverslip (n = 30). Furthermore, it was established in a separate series of experiments that there was no loss of cells during 1.5 h of superfusion (i.e., during the entire length of a superfusion experiment). For all calculations, a cell number of 27,000 cells/coverslip was used.
Determination of the Cell Volume and Intracellular Substrate Concentration. Cells (5 × 106, this amounts to approximately 2 mg of cell protein) were suspended in 1 ml of Krebs-Ringer-HEPES buffer, containing 10 µCi [3H]H2O and 26.4 µCi [14C]inulin and incubated at 37°C for 20 min. The cell pellets were collected by centrifugation at 1000g for 2 min and lysed with 0.1% Triton X-100 (in 5 mM Tris-HCl; pH 7.4). The radioactivity of samples was measured by liquid scintillation counting. Intracellular water space was calculated as the difference between total [3H]H2O space and extracellular [14C]inulin space and amounted to 1.25 ± 0.13 pl/cell (mean ± S.E. of three determination on three different days). Intracellular concentrations were calculated from the accumulated radioactivity in the cells, the above-mentioned value for cell volume and a cell number of 27,000 cells/coverslip.
Chemicals
Tissue culture reagents were from Life Technologies. [3H]MPP+ and [3H]5-HT were from PerkinElmer Life Sciences Products (Boston, MA). para-Chloroamphetamine, imipramine, and 5-HT were from Sigma-Aldrich Handels GmbH (Vienna, Austria) and MPP+ was from RBI/Sigma, Natick, MA). All other chemicals were from commercial sources.
Data Calculation
All curve fitting was done using Prism (GraphPad, San Diego, CA) nonlinear fitting, and plotting software. All results were expressed as mean ± S.E.
| |
Results |
|---|
|
|
|---|
Uptake
Saturation analysis of [3H]5-HT or [3H]MPP+ uptake in HEK 293 cells permanently expressing the hSERT (hSERT cells) revealed decreasing Vmax values with increasing time in culture. Values for [3H]5-HT uptake were 1048 and 160 pmol/min/106 cells after 3.5 and 11 weeks, respectively. Similarly, Vmax values for [3H]MPP+ uptake decreased from 1377 pmol/min/106 cells after 3.5 weeks to 194 pmol/min/106 cells after 7.5 weeks. In parallel uptake experiments performed using both substrates on the same day Vmax values were consistently comparable (Vmax [3H]5-HT/Vmax [3H]MPP+ 0.91 ± 0.06, n = 8, 95% CI, 0.79-1.02). The Km values, however, were constant over time with 0.60 ± 0.07 µM (mean ± S.E. of 22 independent determinations) and 17.0 ± 1.6 µM (mean ± S.E. of 11 independent determinations) for [3H]5-HT and [3H]MPP+, respectively.
The time course of specific accumulation of substrates in hSERT cells
after incubation with 2.5 µM [3H]5-HT and 75 µM [3H]MPP+ is shown in
Fig. 1. Although
[3H]5-HT uptake was linear during the first 10 min only, uptake of
[3H]MPP+ was linear over
the entire 60-min incubation period.
|
Efflux
Intracellular Substrate Concentration.
Efflux experiments were
done by preincubating the cells with labeled substrates (37°C, 20 min) followed by superfusion. After a washout period of 45 min, which
is necessary to establish a stable efflux of radioactivity, the
collection of fractions was started. The relationship between the
concentration of substrate during the preincubation period and the
estimated intracellular substrate concentration at the beginning of
fraction collection (i.e., after the washout) is shown in Fig.
2. Intracellular amounts of
[3H]5-HT and
[3H]MPP+ displayed a
concentration-dependent increase reaching saturation at preincubation
concentrations of 5 and 64 µM, respectively. The maximal
intracellular concentrations reached depended on the time the cells had
been kept in culture. For [3H]5-HT the values
were around 2.5 and 1.2 mM after 3.5 and 8 weeks, respectively. For
[3H]MPP+ an 8-week value
of 5 mM and a 12-week value of 3.5 mM were determined (values for
shorter times in culture not available with
[3H]MPP+ efflux
experiments).
|
|
|
Inward and Outward Transport Rates under Conditions of Reduced
Extracellular Sodium.
Another series of experiments was done in
which uptake initial rates of [3H]5-HT (100 µM) were measured at various Na+
concentrations. There was comparable accumulation of
[3H]5-HT in all buffers containing 10 mM
Na+ or more, whereas marked decreases to 44.2 and
10.5% of control values were observed at 3 and 0 mM
Na+, respectively (Fig.
5A). Subsequently, saturation analyses
for [3H]5-HT uptake at 10 and 120 mM
Na+ were performed. As shown for a representative
experiment in Fig. 5B the Km value for
[3H]5-HT increased at 10 mM
Na+, whereas the Vmax
value did not change. Mean Km values across all analyses increased from 0.6 ± 0.07 µM (n = 22) under 120 mM Na+ to 3.29 ± 0.41 µM
(n = 8) under 10 mM Na+.
|
|
|
|
| |
Discussion |
|---|
|
|
|---|
The aim of the present study was to analyze and to compare
quantitative aspects of inward and outward transport of substrates by
the human SERT to obtain more insight into the mechanisms of carrier-mediated release. As in our previous study on the rat (Sitte et
al., 2000
) and human SERT (Scholze et al., 2000
), we used the natural
substrate 5-HT, and MPP+, a commonly used
substrate for all monoamine transporters (Wall et al., 1995
). 5-HT and
MPP+ differ in their
Km value for the hSERT by a factor of about
25 (0.6 versus 17 µM, respectively) and in their lipophilicity. These differences are the cause of some typical findings, which have been
partly discussed previously (Scholze et al., 2000
; Sitte et al., 2000
)
and will be reviewed here because of their relevance for the present
findings. Because the cells used in the present experiments do not
possess a vesicular storage mechanism, accumulated 5-HT will leave the
cytoplasm by diffusion, but is partly subject to reuptake because of
its high affinity for the hSERT. A reuptake inhibitor such as
imipramine causes a distinct increase in efflux, thus revealing the
total nontransporter-mediated traffic of 5-HT out of the cell (Fig. 3A;
note the linear and nonsaturable relationship between intracellular
[3H]5-HT concentration and efflux rate in Fig.
4A). A similar observation was made by Chen et al. (1998)
regarding
[3H]dopamine efflux and the effect of cocaine
in LLC-PK1 cells expressing the hNET. Therefore, transporter-mediated
efflux of [3H]5-HT was always calculated as
total efflux minus imipramine-induced efflux. By contrast, reuptake of
MPP+ does not take place due to its low
Km value for the hSERT. Imipramine therefore has no effect on
[3H]MPP+ efflux (Fig.
3B), and the observed basal efflux equals total nontransporter-mediated efflux.
For the calculation of intracellular substrate concentrations the cell
volume was determined as intracellular water space, which amounted to
1.25 pl/cell. This converts to 5.25 µl/mg protein, which is in
reasonable agreement with the value of 6.7 µl/mg published by
Schömig for the same cells (Martel et al., 1996
) or the value of
3 µl/mg published by Chen et al. (1998)
for LLC-PK1 cells.
Based on these estimates, the cells apparently accumulated substrates
up to millimolar concentrations. This is in the range of the value
found by and Justice (1998b)
for dopamine (0.52 mM). Reverse transport
was initiated by addition of a saturating concentration of the
5-HT-releasing drug PCA (Rudnick and Wall, 1992b
; Scholze et
al., 2000
). There was an initial acceleration period in efflux lasting
about 5 min followed by a plateau and subsequent substrate depletion
(Fig. 3). The time of 5 min to reach the maximal efflux level was
longer than the time of <2 min for m-tyramine-induced dopamine efflux observed by Chen and Justice (1998a)
using RDEV in hNET
expressing cells. The 2-fold difference may partly be due to the fact
that our superfusion experiments are carried out at 25°C, whereas
RDEV is performed at 37°C, but inherent differences between hNET and
hSERT are also possible. There are at present no efflux data in hSERT
expressing cells that could be used for comparison. The relationship
between the estimated intracellular concentration of 5-HT and rates of
5-HT efflux during the stable phase of PCA-evoked efflux displayed
saturation kinetics (Fig. 4A) with an apparent
Km value of 500- to 1000-fold the value
found for inward transport. Assuming a similar difference for
MPP+, an apparent Km
value in the millimolar range would be expected. It was not possible to
achieve high enough intracellular concentrations experimentally to
perform a correct analysis but a fit using the available data points
rendered an estimate in support of this hypothesis (Fig. 4B).
This marked difference in the Km value for
inward and outward transport may be caused by several factors one of
which is the low intracellular Na+ concentration.
It is well known that the Km value for
substrate transport by monoamine transporters (Graefe and
Bönisch, 1989
) increases at low Na+. In the
present study, the Km value for the inward
transport of 5-HT and MPP+ were about 5-fold
higher at 10 mM Na+ compared with 120 mM
Na+ (Figs. 5B and 6A), which is much less than
the at least 500-fold difference between the
Km values for influx and efflux. Another factor may be competition of substrates inside the cell. It would be
conceivable that PCA, in addition to being taken up, also diffuses into
the cell and reaches concentrations high enough to compete with
intracellular substrate for outward transport. It is noteworthy, however, that a very similar difference in
Km values for in- and outward transport of
dopamine was observed in hNET expressing cells (0.88 versus 396 µM;
Chen and Justice, 1998
).
The Vmax values for both substrates used in
this study depended on the time the cells had been kept in culture, as
also observed by others recently (Qian et al., 1997
; Ramamoorthy and
Blakely, 1999
). However, uptake velocities were comparable for both
substrates when cells with the same time in culture were used in
parallel assays. The Vmax value for
substrate uptake and the maximal velocity of PCA-induced substrate
efflux (Vefflux) displayed a constant relationship independent of time in culture;
Vmax/Vefflux
ratios were 40 and 20 for 5-HT and MPP+,
respectively (Fig. 7). The fact that these ratios are not the same for
the two substrates indicates that the hSERT handles substrates differently with regard to transport direction. This, in turn, may be
explained by a differential influence of the low intracellular sodium
concentration on binding and transport of 5-HT and
MPP+. With this possibility in mind, an
investigation of the sodium dependence of 5-HT transport was performed
(Fig. 5). Lowering the extracellular Na+
concentration to 10 mM did not change the
Vmax value of 5-HT uptake (albeit the
Km value was markedly increased) and also
did not influence Vefflux. Therefore,
Vmax/Vefflux
ratios for 5-HT were the same at 10 and 120 mM
Na+ (Fig. 7A). The same reduction of
Na+ in MPP+ experiments,
however, resulted in a pronounced decline in the Vmax value but no change in
Vefflux. This reduced the
Vmax/Vefflux ratios for MPP+ from 20 at 120 mM
Na+ to 10 at 10 mM Na+
(Fig. 7B). The result clearly indicates that, at least in the case of
MPP+, inward and outward transport by the hSERT
can be independently modulated. This conclusion is further corroborated
by the results of the experiments shown in Fig. 8. When superfusion
assays at 120 and 10 mM Na+ were performed using
5-HT and MPP+ for induction of reverse transport,
there were no differences in substrate induced efflux, although the
Vmax value of MPP+ at
10 mM Na+ is only half of that at 120 mM
Na+. Thus, reverse transport rates did not seem
to be strictly coupled to ratios of inward transport, irrespective
whether the cells were loaded with [3H]5-HT or
[3H]MPP+.
The results of our experiments with lowered extracellular
Na+ suggest that a conformational change of the
hSERT can be induced that is unfavorable for inward transport but does
not affect outward transport. The data may be interpreted in
consonance with our previously formulated hypothesis that releasing
substrates may not only be taken up but may also cause an influx of
sodium ions and thus enhance the possibility of reverse transport
(Sitte et al., 1998
; Pifl and Singer, 1999
) in agreement with a
proposed channel mode of the transporter protein (Sonders and Amara,
1996
; DeFelice and Blakely, 1996
; Beckman and Quick, 1998
). The
hypothesis has received strong support by recent work of Galli et al.
(2000)
who demonstrated in HEK 293 cells expressing the hDAT that 1) amphetamine causes an inward current depolarizing the membrane, and 2)
that intracellular Na+ is required for
amphetamine to commence dopamine efflux. There are also earlier reports
showing requirement for internal Na+ and
Cl
for exchange (Rudnick and Wall,
1992a
,b
) and efflux (Nelson and Rudnick, 1979
, 1982
). However,
given the many possible factors that are likely to determine the
probability of efflux on any given cycle of the transporter (e.g.,
relative rates of conformational changes for influx and efflux, the
internal Na+, Cl
, and
K+ concentrations and membrane potential),
alternative explanations are possible. Thus, efflux may saturate under
conditions where the rate of influx is not maximal (i.e., efflux is
saturated above a threshold of influx).
A native backdrop for independent modulation of carrier-mediated inward
and outward transport at the DAT may be provided by the results of
Gnegy's group who have accumulated evidence that PKC activation may
shift the activity of DATs from supporting inward transport exclusively
to an enhanced tendency for amphetamine-induced efflux (Browman et al.,
1998
; Kantor and Gnegy, 1998
). Finally, Chen and Justice (2000)
, using
site-directed mutagenesis at the DAT, have revealed that a single
mutation can affect only one direction of transport in bidirectional
transport assays (Chen and Justice, 2000
).
In conclusion, the present data provide for the first time information on quantitative aspects of hSERT-mediated reverse transport of substrates. Moreover, they highlight certain features of reverse transport that cannot be reconciled with the classical model of facilitated exchange diffusion.
| |
Acknowledgments |
|---|
We thank H. Bönisch, University of Bonn, Germany, for valuable comments on the work described in this article.
| |
Footnotes |
|---|
Received September 9, 2000; Accepted January 25, 2001
This work was supported by the Austrian Science Foundation, project P13183. Part of the work was presented at the 1) 41st Spring meeting of the German Society of Pharmacology and Toxicology, 2000 March 21-23, Mainz, Germany; and 2) Forum of European Neuroscience, 2000 June 24-28, Brighton, UK. (i) Sitte, HH, Scholze P, Hiptmair B, Pifl C and Singer EA (2000) Transport rates in cells stably expressing the cloned human serotonin transporter: differences in uptake and release. Naunyn-Schmiedeberg's Arch Pharmacol 361(Suppl 4):R29. (ii) Scholze P, Sitte HH, Hiptmair B, Zwach J and Singer EA (2000) Inward and outward transport rates for serotonin and MPP+ (N-methyl-phenylpyridinium) in cells stably expressing the cloned human serotonin transporter. Eur J Neurosci 12(Suppl 11):20.04.
H.H.S. and P.S. contributed equally to this work.
Send reprint requests to: Ernst A. Singer, M.D., Department of Pharmacology, University of Vienna, Waehringerstr. 13A, A-1090 Vienna, Austria. E-mail: ernst.singer{at}univie.ac.at
| |
Abbreviations |
|---|
5-HT, 5-hydroxytryptamine; SERT, serotonin transporter; PCA, p-chloroamphetamine; hSERT, human serotonin transporter; DAT, dopamine transporter; hNET, human norepinephrine transporter; RDEV, rotating disk electrode voltammetry; HEK, human embryonic kidney; MPP+, 1-methyl-4-phenylpyridinium; GFP, green fluorescent protein.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
V. M. Korkhov, M. Holy, M. Freissmuth, and H. H. Sitte The Conserved Glutamate (Glu136) in Transmembrane Domain 2 of the Serotonin Transporter Is Required for the Conformational Switch in the Transport Cycle J. Biol. Chem., May 12, 2006; 281(19): 13439 - 13448. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Seidel, E. A. Singer, H. Just, H. Farhan, P. Scholze, O. Kudlacek, M. Holy, K. Koppatz, P. Krivanek, M. Freissmuth, et al. Amphetamines Take Two to Tango: an Oligomer-Based Counter-Transport Model of Neurotransmitter Transport Explores the Amphetamine Action Mol. Pharmacol., January 1, 2005; 67(1): 140 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Rodriguez, D. L. Roman, K. J. White, D. E. Nichols, and E. L. Barker Distinct Recognition of Substrates by the Human and Drosophila Serotonin Transporters J. Pharmacol. Exp. Ther., July 1, 2003; 306(1): 338 - 346. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Schwartz, R. D. Blakely, and L. J. DeFelice Binding and Transport in Norepinephrine Transporters. REAL-TIME, SPATIALLY RESOLVED ANALYSIS IN SINGLE CELLS USING A FLUORESCENT SUBSTRATE J. Biol. Chem., March 7, 2003; 278(11): 9768 - 9777. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hu and J. B. Becker Effects of Sex and Estrogen on Behavioral Sensitization to Cocaine in Rats J. Neurosci., January 15, 2003; 23(2): 693 - 699. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. V. Adams and L. J. DeFelice Flux Coupling in the Human Serotonin Transporter Biophys. J., December 1, 2002; 83(6): 3268 - 3282. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Scholze, L. Norregaard, E. A. Singer, M. Freissmuth, U. Gether, and H. H. Sitte The Role of Zinc Ions in Reverse Transport Mediated by Monoamine Transporters J. Biol. Chem., June 7, 2002; 277(24): 21505 - 21513. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. S. Ramsey and L. J. DeFelice Serotonin Transporter Function and Pharmacology Are Sensitive to Expression Level. EVIDENCE FOR AN ENDOGENOUS REGULATORY FACTOR J. Biol. Chem., April 19, 2002; 277(17): 14475 - 14482. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||